Harrer T - Search Results

1

Cytotoxic effect of efavirenz is selective against cancer cells and associated with the cannabinoid system.

Hecht M, Harrer T, Büttner M, Schwegler M, Erber S, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. AIDS. 2013 Aug 24;27(13):2031-40. doi: 10.1097/QAD.0b013e3283625444. AIDS. 2013. PMID: 23612009

2

Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes.

Schmitt M, Harrer E, Goldwich A, Bäuerle M, Graedner I, Kalden JR, Harrer T. Schmitt M, et al. Among authors: harrer e, harrer t. AIDS. 2000 Apr 14;14(6):653-8. doi: 10.1097/00002030-200004140-00004. AIDS. 2000. PMID: 10807188

3

Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads.

Hauber I, Harrer T, Löw P, Schmitt M, Schwingel E, Hauber J. Hauber I, et al. Among authors: harrer t. AIDS. 2000 Nov 10;14(16):2619-21. doi: 10.1097/00002030-200011100-00031. AIDS. 2000. PMID: 11101080 No abstract available.

4

A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.

Harrer EG, Bergmann S, Eismann K, Rittmaier M, Goldwich A, Müller SM, Spriewald BM, Harrer T. Harrer EG, et al. Among authors: harrer t. AIDS. 2005 Apr 29;19(7):734-5. doi: 10.1097/01.aids.0000166099.36638.56. AIDS. 2005. PMID: 15821402

5

Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients.

Metzner KJ, Allers K, Rauch P, Harrer T. Metzner KJ, et al. Among authors: harrer t. AIDS. 2007 Mar 30;21(6):703-11. doi: 10.1097/QAD.0b013e3280121ac6. AIDS. 2007. PMID: 17413691

6

Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.

Hofmann C, Harrer T, Kubesch V, Maurer K, Metzner KJ, Eismann K, Bergmann S, Schmitt-Haendle M, Schuler G, Dörrie J, Schaft N. Hofmann C, et al. Among authors: harrer t. AIDS. 2008 Aug 20;22(13):1577-82. doi: 10.1097/QAD.0b013e3283063a17. AIDS. 2008. PMID: 18670216

7

Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells.

Hecht M, Erber S, Harrer T, Klinker H, Roth T, Parsch H, Fiebig N, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. PLoS One. 2015 Jun 18;10(6):e0130277. doi: 10.1371/journal.pone.0130277. eCollection 2015. PLoS One. 2015. PMID: 26086472 Free PMC article.

8

T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.

Mummert C, Hofmann C, Hückelhoven AG, Bergmann S, Mueller-Schmucker SM, Harrer EG, Dörrie J, Schaft N, Harrer T. Mummert C, et al. Among authors: harrer eg, harrer t. AIDS. 2016 Sep 10;30(14):2149-58. doi: 10.1097/QAD.0000000000001176. AIDS. 2016. PMID: 27258398

9

Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation.

Hecht M, Harrer T, Körber V, Sarpong EO, Moser F, Fiebig N, Schwegler M, Stürzl M, Fietkau R, Distel LV. Hecht M, et al. Among authors: harrer t. Oncol Lett. 2018 Feb;15(2):1728-1736. doi: 10.3892/ol.2017.7523. Epub 2017 Dec 5. Oncol Lett. 2018. PMID: 29434868 Free PMC article.

10

Simple algorithm derived from a geno-/phenotypic database to predict HIV-1 protease inhibitor resistance.

Schmidt B, Walter H, Moschik B, Paatz C, van Vaerenbergh K, Vandamme AM, Schmitt M, Harrer T, Uberla K, Korn K. Schmidt B, et al. Among authors: harrer t. AIDS. 2000 Aug 18;14(12):1731-8. doi: 10.1097/00002030-200008180-00007. AIDS. 2000. PMID: 10985309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters